"Chondroitin Sulfates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of chondroitin which have a sulfate moiety esterified to the galactosamine moiety of chondroitin. Chondroitin sulfate A, or chondroitin 4-sulfate, and chondroitin sulfate C, or chondroitin 6-sulfate, have the sulfate esterified in the 4- and 6-positions, respectively. Chondroitin sulfate B (beta heparin; DERMATAN SULFATE) is a misnomer and this compound is not a true chondroitin sulfate.
| Descriptor ID |
D002809
|
| MeSH Number(s) |
D09.698.373.200.300
|
| Concept/Terms |
Chondroitin Sulfates- Chondroitin Sulfates
- Sulfates, Chondroitin
- Chondroitin Sulfate
- Sulfate, Chondroitin
|
Below are MeSH descriptors whose meaning is more general than "Chondroitin Sulfates".
Below are MeSH descriptors whose meaning is more specific than "Chondroitin Sulfates".
This graph shows the total number of publications written about "Chondroitin Sulfates" by people in this website by year, and whether "Chondroitin Sulfates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chondroitin Sulfates" by people in Profiles.
-
Exploiting enzyme specificities in digestions of chondroitin sulfates A and C: production of well-defined hexasaccharides. Glycobiology. 2012 Jun; 22(6):826-38.
-
LC-MS(n) analysis of isomeric chondroitin sulfate oligosaccharides using a chemical derivatization strategy. J Am Soc Mass Spectrom. 2011 Sep; 22(9):1577-87.
-
Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res. 2002 Jul 01; 62(13):3722-8.